STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

about

Blockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs.

P2860

Q50536560-2F75AACD-F415-42B0-AF7F-30D8AB3A6E64

P2860

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

Item

http://www.wikidata.org/entity/Q38685479

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

@en

type

Item

label

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

@en

prefLabel

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

@en

P1476

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

@en

P2093

Chen Liu

http://www.w3.org/2001/XMLSchema#string

Daniel C Peltier

http://www.w3.org/2001/XMLSchema#string

Evelyn C Nieves

http://www.w3.org/2001/XMLSchema#string

Hiroya Tamaki

http://www.w3.org/2001/XMLSchema#string

Katherine Oravecz-Wilson

http://www.w3.org/2001/XMLSchema#string

Pavan Reddy

http://www.w3.org/2001/XMLSchema#string

Tomomi Toubai

http://www.w3.org/2001/XMLSchema#string

Yaping Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial

Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions.

Mouse lysozyme M gene: isolation, characterization, and expression studies.

Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.

STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model

Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD

CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.

P31

scholarly article

P356

10.1016/J.BBMT.2017.06.018

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28694183

http://www.w3.org/2001/XMLSchema#string

P932

6088768

http://www.w3.org/2001/XMLSchema#string

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

about

P2860

P2860

STAT3 Expression in Host Myeloid Cells Controls Graft-versus-Host Disease Severity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P932